News for Environmental Impact Acquisition Corp. (ENVIU)

INDEX TO FINANCIAL STATEMENTS Page ... | September 26, 2022

Last year was a banner year for special-purpose acquisition companies, but so far it’s unclear if this year will pan out to be nearly as active for the SPAC market.

GreenLight Biosciences makes affordable and accessible RNA products for human health and agriculture. Read more about GRNA stock here.

Trinity Capital Inc. (NASDAQ:TRIN) Q4 2021 Earnings Conference Call March 03, 2022 05:00 PM ET Company Participants Sarah Stanton - General Counsel Steve Brown - Chairman & Chief...

Last year was a banner year for special-purpose acquisition companies, but so far it’s unclear if this year will pan out to be nearly as active for the SPAC market.

/PRNewswire/ -- GreenLight Biosciences ("GreenLight"), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible...

/PRNewswire/ -- GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership...

BOSTON, Jan. 14, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation , a publicly-traded special purpose acquisition company, announced today that ENVI's definitive proxy... | January 14, 2022

BOSTON, Jan. 14, 2022 /PRNewswire/ -- Environmental Impact Acquisition Corporation (NASDAQ: ENVI) ('ENVI'), a publicly-traded special purpose acqu...